解毒疏肝汤联合穴位贴敷在肝癌介入治疗患者中的应用  

Application of Jiedu Shugan decoction combined with acupoint application in patients with liver cancer undergoing interventional therapy

作　　者：韩永强 刘鑫 HAN Yongqiang;LIU Xin(Department of Traditional Chinese Medicine,Dancheng County People's Hospital,Zhoukou 477150,Henan,China)

机构地区：[1]郸城县人民医院中医科,河南周口477150

出　　处：《中国民族医药杂志》2025年第2期6-8,共3页Journal of Medicine and Pharmacy of Chinese Minorities

摘　　要：目的:探讨解毒疏肝汤联合穴位贴敷在肝癌介入治疗患者中的应用效果。方法:选取郸城县人民医院2021年3月—2023年9月行TACE治疗的患者80例,患者按照随机数字表法分为两组,各40例。两组患者均行肝动脉化疗栓塞术治疗,治疗后对照组给予解毒疏肝汤,观察组加用穴位贴敷。结果:观察组疗效总有效率高于对照组(P<0.05);观察组恶心呕吐、肝区疼痛、黄疸、腹胀持续时间短于对照组(P<0.05);两组患者治疗期间均未发生明显不良反应。结论:解毒疏肝汤联合穴位贴敷可提升于肝癌介入治疗患者的临床疗效,有效缓解症状,且未出现明显不良反应。Objective:To explore the application effect of Jiedu Shugan decoction combined with acupoint application in patients with liver cancer undergoing interventional therapy.Method:80 patients were randomly divided into two groups using a random number table method,with 40 cases in each group.Both groups of patients underwent transcatheter arterial chemoembolization treatment.After treatment,the control group was given Jiedu Shugan Tang,while the observation group was given acupoint application.Result:The total effective rate of the observation group was higher than that of the control group(P<0.05).The duration of nausea,vomiting,liver pain,jaundice,and abdominal distension symptoms in the observation group was shorter than that in the control group(P<0.05).Both groups of patients did not experience significant adverse reactions during treatment.Conclusion:Jiedu Shugan decoction combined with acupoint application can improve the clinical efficacy of patients with liver cancer interventional therapy,effectively relieve symptoms,and there is no obvious adverse reaction.

关 键 词：肝癌 介入治疗 解毒疏肝汤 穴位贴敷 恶心呕吐 

分 类 号：R735.7[医药卫生—肿瘤]